News Headlines Article

FDA warns drug middleman for sending unsafe drugs to U.S.
Modern Healthcare

The U.S. Food and Drug Administration sent a warning letter Thursday to CanaRx, a pharmaceutical middleman that is endangering consumers by allegedly selling unapproved, misbranded and unsafe drugs.

CanaRx acts as a broker between foreign pharmacies and employer-sponsored health insurance plans. As of 2017, the intermediary contracted with more than 150 public and private employers in about 35 states, the FDA said.

CanaRx accepts the employee’s U.S. prescription and a foreign doctor rewrites the prescription filled with drugs from an unknown source. The drugs, purportedly sourced from Canada, the United Kingdom or Australia, are then shipped directly to the employee with the standard disclaimer—”Depending on your country, our medications may appear to be different in size, shape or color.”